3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Terminated
2
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Non-small Cell Lung Cancer Metastatic
2
Neoplasms
2
Non-squamous Non-small-cell Lung Cancer (NSQ NSCLC)
1
Non-squamous Non-small Cell Lung Cancer
1
Breast Cancer Metastatic
1
Adenocarcinoma Gastric
1
Interventions
tusamitamab ravtansine
2
Gemcitabine
2
pembrolizumab
1
necitumumab
1
Ramucirumab
1
MLN 8237
1
LY3023414
1
Gefitinib
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Non-small Cell Lung Cancer Metastatic
×
tusamitamab ravtansine
×
Clear all
NCT04154956
2026-05-18
CARMEN-LC03
Sanofi
Phase 3
Terminated
389 enrolled
16 charts
NCT04394624
2025-06-06
CARMEN-LC04
Sanofi
Phase 2
Terminated
31 enrolled
22 charts